Sort
40,608 grants matching “prostate cancer”
MID ATLANTIC PROSTATE CANCER BANK
$628,670George Washington University · U01 · FY2004 · CA
Defining the epigenetic landscape in human prostate cancer
$628,587Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Defining the epigenetic landscape in human prostate cancer
$628,587Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Motion-Resolved, Comprehensive Quantitative Tissue Characterization Using MR Multitasking
$628,575Debiao Li · Cedars-Sinai Medical Center · R01 · FY2022 · EB
Motion-Resolved, Comprehensive Quantitative Tissue Characterization Using MR Multitasking
$628,575Debiao Li · Cedars-Sinai Medical Center · R01 · FY2020 · EB
Evaluating Lung Cancer Screening Patterns and Outcomes through a North Carolina Registry
$628,514Louise Henderson · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
Adiposity and Outcomes of Clinically Localized Prostate Cancer
$628,470Vincent L Freeman · University Of Illinois At Chicago · R01 · FY2010 · CA
Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer
$628,354Christian Maximillian Schmidt · Indiana University Indianapolis · U01 · FY2024 · CA
PET-determined prostate brachytherapy dosing using intraoperative image-guidance
$628,096Daniel Song · Johns Hopkins University · R01 · FY2018 · CA
Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients
$628,081Amy Jude Hoffman · University Of Nebraska Medical Center · R01 · FY2018 · CA
10-year Comparative Effectiveness and Harms of Treatments for Prostate Cancer
$628,064Daniel A Barocas · Vanderbilt University Medical Center · R01 · FY2021 · CA
Precision magnetic hyperthermia by integrating magnetic particle imaging
$628,016Jeff W Bulte · Johns Hopkins University · R01 · FY2025 · CA
Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development
$627,973Owen N Witte · University Of California Los Angeles · R01 · FY2019 · CA
Delineating the underlying reasons for the racial disparity in gastric cancer incidence in the United States
$627,947Meira Epplein · Duke University · R01 · FY2023 · CA
CLINICAL TRANSLATION OF HYPERPOLARIZED 13C-UREA FOR CANCER MR MOLECULAR IMAGING
$627,880John Kurhanewicz · University Of California, San Francisco · R01 · FY2019 · CA
Effect of Aerobic Exercise on Genomic Signatures of Prostate Cancer Prognosis
$627,846June Ml Chan · University Of California, San Francisco · R01 · FY2017 · CA
Pharmacogenetic Studies
$627,804Neil E. Caporaso · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Prognostic and Predictive Digital Tissue Image Assay for Prostate Cancer
$627,645Anant Madabhushi · Emory University · R01 · FY2023 · CA
Optimizing Theranostic Dosimetry and Kidney Biomarkers for Alpha-Emitter Radioligand Therapy in Neuroendocrine Tumors
$627,573Diana Zepeda-Orozco · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · CA
Focal Laser Ablation of Prostate Cancer using MR/US Fusion
$627,518Leonard Stephen Marks · University Of California Los Angeles · R01 · FY2017 · CA
Mapping the epigenetic dynamics of prostate cancer progression: integrating liquid biopsies and single-cell epigenomics for early detection of lineage plasticity and clinical decision-making
$627,474Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Addressing Misinformation to Promote Equity in Prostate Cancer Care
$627,381Stacy Loeb · New York University School Of Medicine · R01 · FY2023 · CA
NCI NCTN- Network Lead Academic Participating Site: USC
$627,370Heinz Josef Lenz · University Of Southern California · U10 · FY2016 · CA
Translational Pathology Core
$627,284Peter A Jones · University Of Southern California · P30 · FY2013 · CA
Validation, Calibration, and Translation of Restriction Spectrum Imaging Signal Maps to enhance MRI diagnostic capabilities in Prostate Cancer
$627,248Michael Andre Liss · University Of California, San Diego · R01 · FY2025 · CA